Please turn JavaScript on
Biotech Investments icon

Biotech Investments

Receive updates from Biotech Investments for free, starting right now.

We can deliver them by email, via your phone or you can read them from a personalised news page on follow.it.

This way you won't miss any new article from Biotech Investments. Unsubscribe at any time.

Site title: Biotech Investments – Independent Medical Rating Agency for Biotech and Pharmaceutical Assets. Purpose-built for Investors and Industry Partners.

Is this your feed? Claim it!

Publisher:  Unclaimed!
Message frequency:  6.26 / day

Message History

Gerresheimer AG

Gerresheimer AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

19.09.2026 / 08:53 CET/CEST

Dissemination of a Voting Rights Announcement transmitted by


Read full story

Gerresheimer AG

Gerresheimer AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

19.09.2026 / 08:50 CET/CEST

Dissemination of a Voting Rights Announcement transmitted by


Read full story

Bayer Aktiengesellschaft

Bayer AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

18.09.2026 / 10:04 CET/CEST

Dissemination of a Voting Rights Announcement transmitted by


Read full story

MEDIA RELEASE
 

Agreement for emicizumab biosimilar in reference market worth USD 5.7 billion; marks first haemophilia biosimilar in pipeline Provides basis for evaluating potential future collaboration opportunities based on shared commitment to expanding access to biosimilar medicines Strengthens Sandoz position in biosimilars and further expands industry-...

Read full story

Ad hoc announcement pursuant to art. 53 SIX Swiss Exchange Listing Rules

MEDIA RELEASE
 

Potential to expand patient access to semaglutide treatment option in Canada and support local healthcare system Builds on recent Sandoz GLP-1 milestones: tirzepatide FDA file acceptance in US and semaglutide regulatory approval in Brazil Nearly six ...

Read full story